Arma Biosciences was founded to commercialize a new sensor technology for biomolecular analytes relevant to the management of chronic disease and wellness, and it supplies that technology as a bare sensor, a packaged consumable, or a whole product. Post-processing chemistries turn standard printed circuit boards into sensor substrates, and patented Recruitment Pendulums and an anti-fouling Bio-Barrier enable wash-free electrochemical sensing on low-cost printed-circuit-board substrates.
The company's category is a reprogrammable, universal sensing layer for point-of-care and distributed diagnostics, and point-of-care and distributed diagnostics companies build their products on it. Readings take minutes from blood, saliva, urine, and plasma samples without a laboratory, microfluidics, or sample preparation. Sending blood samples to a central laboratory instead costs a day or more.
